Early-onset group B streptococcal (GBS) infection can be prevented by intrapartum antibiotic prophylaxis. In the USA the effectiveness of this strategy was demonstrated after the introduction of formal guidelines in 1996. In Europe prevention strategies for early-onset GBS infection have not been implemented universally. In 1998 the Dutch Society of Paediatrics and the Dutch Society of Obstetrics and Gynaecology posted conjoint guidelines for the prevention of early-onset GBS disease based on currently available knowledge and the local situation. These guidelines will be discussed in this overview.</p
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Problem: Despite the introduction of preventive guidelines, no decrease in the incidence of early on...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the...
We sent a questionnaire to all members of the European Society for Paediatric Infectious Diseases an...
Streptococcus agalactiae, or group B streptococcus (GBS), remains the leading cause of neonatal seps...
The prevalence of maternal group-B-streptococcus (GBS) colonization and risk factors (RFs) for neona...
The prevalence of maternal group-B-streptococcus (GBS) colonization and risk factors (RFs) for neona...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the ...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the ...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the ...
Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections...
Early-onset Group B haemolytic streptococcus infection (EOGBS) is an important cause of neonatal mor...
Problem: Despite the introduction of preventive guidelines, no decrease in the incidence of early on...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Problem: Despite the introduction of preventive guidelines, no decrease in the incidence of early on...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the...
We sent a questionnaire to all members of the European Society for Paediatric Infectious Diseases an...
Streptococcus agalactiae, or group B streptococcus (GBS), remains the leading cause of neonatal seps...
The prevalence of maternal group-B-streptococcus (GBS) colonization and risk factors (RFs) for neona...
The prevalence of maternal group-B-streptococcus (GBS) colonization and risk factors (RFs) for neona...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the ...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the ...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal disease. Since the ...
Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS infections...
Early-onset Group B haemolytic streptococcus infection (EOGBS) is an important cause of neonatal mor...
Problem: Despite the introduction of preventive guidelines, no decrease in the incidence of early on...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...
Problem: Despite the introduction of preventive guidelines, no decrease in the incidence of early on...
The purpose of this paper was to present the current knowledge on the prevention of group B streptoc...